lilly glp 1 drug Study flags need to monitor frailty risks with GLP-1 drugs for older adults Eli Lilly's GLP-1 pill hit

Its hard enough to imagine a vitamin being carcinogenic on its own and even more so one that somehow affects only men and not women, too

Use of DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT-2 inhibitors is on the rise owing, at least in part, to their glycemic benefits, lack of weight gain, and complementary mechanisms of action when used in combination with metformin or other antihyperglycemic medication classes

noted that the research on body losses is relatively old, inconsistent, and it might not be further clarified due to the ethical concerns with using radioisotopes for tracking B12 in the body

Nasrin N, Wu X, Fortier E, Feng Y, Bare OC, Chen S, Ren X, Wu Z, Streeper RS, Bordone L (2010) SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells

Background care (concomitant use of statins, angiotensin converting enzyme inhibitors /angiotensin receptor blockers, beta-blockers and dual antiplatelet therapy) may also play a role in this discrepancy

MontezanoACTouyzRM.Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies